IQVIA Holdings Inc

Research IQVIA Holdings Inc (IQV) on Bullrun: valuation model: 2.6% undervalued, market cap USD 32.26B, P/E 24.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIQV
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Valuation signal2.6% undervalued
• Market capUSD 32.26B
• P/E24.0
• Financial periodFY2025
• RevenueUSD 16.31B
• Revenue growth5.9%
• Net incomeUSD 1.36B
• Free cash flowUSD 2.05B

Valuation Snapshot

Bullrun's latest valuation model marks IQVIA Holdings Inc as 2.6% undervalued; latest market cap is USD 32.26B; P/E is 24.0.

About IQVIA Holdings Inc

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services;

Frequently asked questions

Is IQVIA Holdings Inc overvalued or undervalued?

Bullrun's valuation model currently marks IQVIA Holdings Inc as 2.6% undervalued.

What is IQVIA Holdings Inc's market cap?

IQVIA Holdings Inc's market capitalization is USD 32.26B.

What is IQVIA Holdings Inc's P/E ratio?

IQVIA Holdings Inc's price-to-earnings (P/E) ratio is 24.0.

What does IQVIA Holdings Inc do?

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.